Bringing the fundamentals into focus…
Back to Kura Oncology, Inc.
How Kura Oncology, Inc. stacks up
KURA · against 444 other Healthcare companies of similar size
Growth
56/ 100
Above the middle of the pack.
Ranked #178 of 445 · scores higher than 59% of peers
Bars: peers in each 10-point band of the growth score38 peers with a growth score of 50–59, including KURA · Click a bar to see the companies
Why growth scores 56?
Weighted metrics compared with all Healthcare companies.A mix: stronger revenue growth, but weaker earnings per share growth than most Healthcare peers.
- The loss per share widened. Earnings per share growth: — vs peer median 9.8%
- 3-year revenue growth is not reported, so it is left out of the score.
- faster revenue growth over the last year: stronger than 83% of peers. Revenue growth: 25.2% vs peer median 6.1%
Metric by metric
Position: dot = KURA, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | KURA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 453 reported | 25.2% | 4.1% | 87% | 33% | |
| Earnings per share growthHigher is better · 240 reported | Not reported | 5.2% | — | — | 33% |
| 3-year revenue growthHigher is better · 439 reported | Not reported | 4.8% | — | — | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around KURA| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 885M USD | 99 | 33 | |
| 2 | 609M USD | 99 | 91 | |
| 172 | 18.7B THB (≈$525M) | 57 | 55 | |
| 178 | 3.2B CNY (≈$451M) | 56 | 60 | |
| 178 | 3.3B CNY (≈$458M) | 56 | 49 | |
| 178 | 73.8B JPY (≈$502M) | 56 | 62 | |
| 178 | 879M USD | 56 | 36 | |
| 182 | 13.9B SEK (≈$1.4B) | 55 | 48 | |
| 182 | 51.2B INR (≈$614M) | 55 | 63 | |
| 182 | 2.2B CAD (≈$1.6B) | 55 | 44 | |
| 185 | 7.2B CNY (≈$1.0B) | 54 | 56 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score